Validity of physical activity monitors during daily life in patients with COPD.
Roberto A Rabinovich, Zafeiris Louvaris, Yogini Raste...
https://pubmed.ncbi.nlm.nih.gov/23397303Actively Recruiting
Age: 18Years - 75Years
All Genders
Healthy Volunteers
ID06666816
Observational Study for the Identification of Fatigue and Gait Biomarkers in Neuromuscular Diseases During Clinical Tests and Daily Life Monitoring
Led by IRCCS Eugenio Medea · Updated on 2026-01-20
120
Participants Needed
2
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are observing walking patterns and fatigue in adults with neuromuscular diseases such as muscular dystrophies, myopathies, spinal muscular atrophy, and Charcot-Marie Tooth disease. The study aims to objectively measure fatigue through clinical walking tests and to explore how feasible it is to collect physical activity data during daily life using wearable sensors over a one-week period. Participants include adults aged 18 to 75 who can walk independently, with or without assistance. The study involves observing walking speed variability during a six-minute walking test and monitoring physical activity in everyday settings using wearable devices. Both patients with neuromuscular diseases and a control group are included for comparison. During the study, participants will undergo a six-minute walking test to assess changes in walking speed and gait variability. Subjective fatigue levels and clinical progression of their neuromuscular condition will also be recorded. Physical activity will be monitored for one week with wearable sensors to gather data on daily life movements. The study includes healthy volunteers and runs until December 2026.
CONDITIONS
Brief Title
Observational Study to Observe Variations of Gait Parameters in Patients With Neuromuscular Diseases
Who Can Participate
Age: 18Years - 75Years
All Genders
Healthy Volunteers
Eligibility Criteria
You may qualify if you...
- Adult patients aged 18 to 75 with a genetic diagnosis of muscular dystrophy, myopathy, spinal muscular atrophy, or Charcot-Marie Tooth disease
- Able to walk independently, with or without assistance
You will not qualify if you...
- Moderate dilated or ischemic heart disease
- Chronic respiratory failure with forced vital capacity less than 40%
- Spending more than 5% of the night with oxygen saturation below 90%
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Diagnostic Evaluation
Duration - 1 day
Participants undergo clinical tests to assess gait parameters and fatigue levels.
1 visit (in-person)
Long-term Monitoring
Duration - Up to 6 months
Participants are observed during daily life to monitor variations in gait and fatigue over time.
Periodic assessments depending on participant availability
Trial Site Locations
Total: 2 locations
1
Scientific Institute IRCCS E. Medea - Sede di Bosisio Parini
Bosisio Parini, Lecco, Italy, 23842
Actively Recruiting
2
Scientific Institute IRCCS E. Medea - Polo di Conegliano
Conegliano, Treviso, Italy, 31015
Not Yet Recruiting
Loading map...
Research Team
F
Fabio A Storm, PhD
E
Emilia Biffi, PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients.
Jessica M O'Hagen, Allan M Glanzman, Michael P McDermott...
https://pubmed.ncbi.nlm.nih.gov/17658255A motor function measure for neuromuscular diseases. Construction and validation study.
Carole Bérard, Christine Payan, Isabelle Hodgkinson...
https://pubmed.ncbi.nlm.nih.gov/16106528The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus.
L B Krupp, N G LaRocca, J Muir-Nash...
https://pubmed.ncbi.nlm.nih.gov/2803071ATS statement: guidelines for the six-minute walk test.
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories
https://pubmed.ncbi.nlm.nih.gov/12091180Erratum: ATS Statement: Guidelines for the Six-Minute Walk Test.
https://pubmed.ncbi.nlm.nih.gov/27174486Connecting real-world digital mobility assessment to clinical outcomes for regulatory and clinical endorsement-the Mobilise-D study protocol.
A Stefanie Mikolaizak, Lynn Rochester, Walter Maetzler...
https://pubmed.ncbi.nlm.nih.gov/36201476Technical validation of real-world monitoring of gait: a multicentric observational study.
Claudia Mazzà, Lisa Alcock, Kamiar Aminian...
https://pubmed.ncbi.nlm.nih.gov/34857567Free-living and laboratory gait characteristics in patients with multiple sclerosis.
Fabio A Storm, K P S Nair, Alison J Clarke...
https://pubmed.ncbi.nlm.nih.gov/29715279Need for Digital Biomarkers in Musculoskeletal Trials.
Jörg Goldhahn
https://pubmed.ncbi.nlm.nih.gov/32095748